# Renal Denervation Devices Market and Forecast 2025-2033

Limited-Time Offer \[Flat 15% Discount\] [Dismiss](#)

[Skip to content](#content "Skip to content")

[Updated Data Matrix Available](https://www.ihealthcareanalyst.com/research-services/)

Market Value | Market Volume | Epidemiology | Clinical Trials | Patent Landscape | Regulatory Approvals

[Home](https://www.ihealthcareanalyst.com/) » [Reports](https://www.ihealthcareanalyst.com/shop/) » [Medical Devices](https://www.ihealthcareanalyst.com/reports/medical-devices/)

![Awaiting product image](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)

![Awaiting product image](https://www.ihealthcareanalyst.com/wp-content/uploads/2019/08/report-icon4-e1565791186498.png)

# Renal Denervation Devices Market by Product/Brand \[Simplicity Renal Denervation System, EnligHTN Multi-Electrode Renal Denervation System, Iberis Renal Sympathetic Denervation System, Vessix Vascular (V2) Renal Denervation System, Paradise Renal Denervation System, Other Systems (Therapeutic Intra-Vascular Ultrasound (TIVUS), Bullfrog Micro-Infusion Catheter)\], Technology (Radiofrequency-Based Renal Denervation System, Ultrasound-Based Renal Denervation System, Micro-Infusion Catheter-Based Renal Denervation System) and Forecast 2025-2033

$3,000.00

## Report Specifications: Market Size, Market Share, Growth Trends, Forecast, Geography

Renal denervation is a minimal invasive procedure. It is used for the treatment of drug resistant or treatment resistant hypertension. This procedure reduces blood pressure by ablation of renal nerves. This procedure has certain benefits like shorter treatment timed permanent effects over drug treatment which in turn reduces the cost of treatment. These benefits tend to drive the market.

The global renal denervation devices market report provides market size ($Million 2023 to 2033), market share and forecast (CAGR%, 2025 to 2033).

The global renal denervation devices market segmentation is based on product/brand \[Simplicity renal denervation system, EnligHTN Multi-Electrode renal denervation systemm, Iberis renal sympathetic denervation system, Vessix Vascular (V2) renal denervation system, Paradise renal denervation system, Other systems (Therapeutic Intra-Vascular Ultrasound, Bullfrog Micro-Infusion Catheter)\], technology (radiofrequency-based renal denervation system, ultrasound-based renal denervation system, micro-infusion catheter-based renal denervation system), and geography.

The global renal denervation devices market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.

The global renal denervation devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments.

Major players operating in global renal denervation products market and included in the report are Abbott Laboratories, Inc. (St. Jude Medical, Inc.), Ablative Solutions, Inc., Boston Scientific Corporation, Cordis Corporation, Medtronic plc (Covidien plc), Mercator Medsystems, Inc., Otsuka Medical Devices Co., Ltd. (ReCor Medical, Inc.), Renal Dynamics LLC, SoniVie (CardioSonic, Inc.), and Terumo Corporation.

**DATA INCLUDED:** Renal Denervation Devices Market Size, Renal Denervation Devices Market Share, Renal Denervation Devices Market Growth Rates, Renal Denervation Devices Market Trends, and Renal Denervation Devices Market Forecast to 2033

**Market Data:**

*   Estimation Base Year: 2024
*   Historical Data Range: 2023-2024
*   Forecast Period: 2025-2033
*   Market Representation: Revenue in $million and CAGR % from 2025 to 2033
*   Regional Scope: North America, Europe, Asia Pacific, Latin America, Rest of the World (Middle East & Africa)
*   Country Scope: U.S., Canada, U.K., Germany, France, Italy, Spain, Japan, China, India, South Korea, Brazil, Mexico, South Africa, South Korea, Saudi Arabia, UAE, and other countries.
*   Report Coverage: Revenue forecasts, company market share, competitive landscape analysis, growth factors, and market trends
*   Customization Scope (15% Free): Accommodation of specific or custom requirements beyond the current report scope.

**Qualitative Analysis:**

*   Industry Overview
*   Industry Trends
*   Market Driver, Restraints, and Opportunities
*   Market Size
*   Growth Trends
*   Porter’s Five Forces Analysis
*   Market Attractiveness Matrix
*   Competitive Landscape
    *   Company Overview
    *   Financial Performance
    *   Product Portfolio
    *   Strategic Insights
    *   Recent Developments

**Quantitative Analysis:**

*   Market Size Projections: Comprehensive estimates and forecasts for all segments
*   Regional Market Analysis: Estimates and forecasts for key countries
*   Corporate Financial Performance: Analysis of company financials
*   Competitive Landscape: Market share analysis of leading companies

Choose License Type

Choose an optionSingle-user LicenseMulti-user LicenseCorporate License[Clear](#)

Renal Denervation Devices Market by Product/Brand \[Simplicity Renal Denervation System, EnligHTN Multi-Electrode Renal Denervation System, Iberis Renal Sympathetic Denervation System, Vessix Vascular (V2) Renal Denervation System, Paradise Renal Denervation System, Other Systems (Therapeutic Intra-Vascular Ultrasound (TIVUS), Bullfrog Micro-Infusion Catheter)\], Technology (Radiofrequency-Based Renal Denervation System, Ultrasound-Based Renal Denervation System, Micro-Infusion Catheter-Based Renal Denervation System) and Forecast 2025-2033 quantity 

Buy Report   

For inquiries regarding discounts on single or bundled report purchases, please reach out to us.

*   [Table of Contents MD](#tab-table-of-contents-md)
*   [Market Segments and Companies](#tab-market-segments-and-companies)
*   [Request ToC / Sample](#tab-request-toc-sample-discount)

1.  **Introduction**
2.  **Executive Summary**
    *   Market Size Estimation ($million, 2023-2033)
    *   Forecast Estimation ($million and CAGR%, 2025-2033)
3.  [**Research Methodology**](https://www.ihealthcareanalyst.com/research-methodology/)
4.  **Market Landscape**
    *   Market Dynamics
        *   Drivers
        *   Barriers
        *   Opportunities
    *   Market Share Analysis
        *   Companies
        *   Devices
    *   Market Trends Analysis
        *   Key success factors
        *   Market Growth Rate
    *   Market Attractiveness Analysis
    *   Market Profitability Analysis
        *   Buyer power
        *   Supplier power
        *   Barriers to entry
        *   Threat of substitute products
        *   Rivalry among firms in the industry
    *   Distribution Channels
5.  **Market Segmentation** \[_refer Market Segments and Companies Tab_\]
    *   Device or Brand Type
    *   Diagnostic Test
    *   Indication Type
    *   Technology
    *   Diagnostics, Therapeutic or Surgical Application
    *   End User Groups
6.  **Geography (Region, Country)**
    *   North America (U.S., Canada)
    *   Europe (U.K., Germany, France, Italy, Spain, Rest of EU)
    *   Asia Pacific (Japan, China, India, Rest of APAC)
    *   Latin America (Brazil, Mexico, Rest of LA)
    *   Rest of the World (Middle East & Africa)
7.  **Regulatory Overview** 
    *   Device Classification I, II, III, IV
    *   Device (FDA, EMEA) Approvals
8.  **Company Profiles** \[_refer Market Segments and Companies Tab_\]
    *   Company Overview
    *   Financial Snapshot
    *   Product Portfolio
    *   Business Strategies
    *   Recent Developments
9.  **Recommendations**
10.  **References**

**Key Questions Answered:**  
1\. What are the factors driving and limiting this market, key success factors and challenges?  
2\. Which are the leading competitors in the market, their market share, profitability and key trends by product, technology, services portfolio?  
3\. How do markets perform between countries and regions?  
4\. What market segments are contributing to maximum share and greatest growth?  
5\. What is the product or procedure volumes by country and regions?

**Actionable Insights Included:**  
1\. Product portfolio matrix (Share vs. Growth)  
2\. Market attractiveness (Region vs. Growth)  
3\. Spot matrix (Product vs. Region)  
4\. Geographic distribution matrix (Share vs. Growth)

**Renal Denervation Devices Market**

1\. **Product (Brand)**  
1.1. Simplicity Renal Denervation System  
1.2. EnligHTN Multi-Electrode Renal Denervation System  
1.3. Iberis Renal Sympathetic Denervation System  
1.4. Vessix Vascular (V2) Renal Denervation System  
1.5. Paradise Renal Denervation System  
1.6. Other Systems  
1.6.1. Therapeutic Intra Vascular Ultrasound (TIVUS)  
1.6.2. Bullfrog Micro-Infusion Catheters

2\. **Technology**  
2.1. Radiofrequency-based Renal Denervation System  
2.2. Ultrasound-based Renal Denervation System  
2.3. Micro-infusion Catheter-based Renal Denervation System

3\. **Geography**  
3.1. North America (U.S., Canada)  
3.2. Europe (U.K., Germany, France, Italy, Spain, Rest of EU)  
3.3. Asia Pacific (Japan, China, India, Rest of APAC)  
3.4. Latin America (Brazil, Mexico, Rest of LA)  
3.5. Rest of the World

4\. **Company Profiles**  
4.1. Abbott Laboratories, Inc. (St. Jude Medical, Inc.)  
4.2. Ablative Solutions, Inc.  
4.3. Boston Scientific Corporation  
4.4. Cordis Corporation  
4.5. Medtronic plc (Covidien plc)  
4.6. Mercator Medsystems, Inc.  
4.7. Otsuka Medical Devices Co., Ltd. (ReCor Medical, Inc.)  
4.8. Renal Dynamics LLC  
4.9. SoniVie (CardioSonic, Inc.)  
4.10. Terumo Corporation

**Request Table of Contents / Sample Report**

Full Name\*

Company Email\*

Phone Number\* \[Please add country code\]

Subject\*

Message\*

Resource Links

*   [About Us](https://www.ihealthcareanalyst.com/about/)
*   [Clinical Trials](https://www.ihealthcareanalyst.com/clinical-trials-dashboard/)
*   [Drugs@FDA](https://www.ihealthcareanalyst.com/drugs-fda-dashboard/)
*   [Orange Book](https://www.ihealthcareanalyst.com/orange-book-dashboard/)
*   [Premarket Approval](https://www.ihealthcareanalyst.com/premarket-approval-pma/)
*   [Premarket Notification](https://www.ihealthcareanalyst.com/premarket-notification-510k/)
*   [Publications](https://www.ihealthcareanalyst.com/publications/)

Terms and Conditions

*   [FAQs](https://www.ihealthcareanalyst.com/faqs/)
*   [Careers](https://www.ihealthcareanalyst.com/careers/)
*   [Terms of Use](https://www.ihealthcareanalyst.com/terms/)
*   [How to Order](https://www.ihealthcareanalyst.com/order/)
*   [Return Policy](https://www.ihealthcareanalyst.com/return/)
*   [Privacy Policy](https://www.ihealthcareanalyst.com/privacy/)
*   [Disclaimer Policy](https://www.ihealthcareanalyst.com/disclaimer/)

Secure Online Payment

![iHealthcareAnalyst, Inc.](https://www.ihealthcareanalyst.com/wp-content/uploads/2018/07/creditcard-payment-logos-300x48.jpg)

Search

Search

Contact Address

**US Office:** 2109, Mckelvey Hill Drive, Maryland Heights, MO 63043, United States  
Phone: +1 (314) 315-4764  
**India Office:** 5, Shilpa Chambers, Opp. J. M. Road, Shivajinager, Pune 411005, India  
Phone: +91 (20) 25898524  
Email: [\[email protected\]](/cdn-cgi/l/email-protection#344755585147745d5c515558405c57554651555a55584d47401a575b59)

[](# "Scroll back to top")

Search for: